Allogeneic hematopoietic cell transplant in HCV-infected patients

Journal of Hepatology
Régis Peffault de LatourTarik Asselah

Abstract

Hepatitis C virus (HCV) is a major cause of liver disease worldwide. After allogeneic Hematopoietic Cell Transplant (HCT), HCV is known to be associated with transient hepatitis in the immediate post-transplant period, and a potential risk factor of veno-occlusive disease (SOS). Very recently, HCV-infected HCT recipients have been shown to be at higher risk of earlier cirrhosis, leading to greater morbidity and mortality. Long-term survivors after HCT are thus at a high risk for HCV-related complications and, as a consequence, the treatment of HCV infection becomes critical. We describe here the potential clinical complications in HCV-infected recipients, in the short, but also the long-term follow-up after HCT. The pathophysiology of liver fibrosis is discussed as well as the present recommended therapy in this particular population.

References

May 1, 1988·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H M ShulmanG B McDonald
Feb 1, 1994·Transplantation·F NorolJ P Vernant
Jan 1, 1995·Journal of Gastroenterology and Hepatology·G M ForbesB J Collins
Sep 1, 1993·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A S LokG Kuo
May 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H M ShulmanG B McDonald
Mar 28, 1996·The New England Journal of Medicine·E J GaneR Williams
Jul 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P LjungmanJ Winiarski
Sep 26, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Aug 26, 1998·Bone Marrow Transplantation·S I StrasserG B McDonald
May 29, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S I StrasserG B McDonald
Nov 28, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S I StrasserG B McDonald
Jul 7, 2001·The New England Journal of Medicine·G M Lauer, B D Walker
Dec 4, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·V Di MartinoP Marcellin
Jan 5, 2002·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Hervé ZylberbergStanislas Pol
Jan 10, 2002·The Journal of Experimental Medicine·Stefania CrottaNicholas M Valiante
Jan 10, 2002·The Journal of Experimental Medicine·Chien-Te K Tseng, Gary R Klimpel
Jan 17, 2002·The New England Journal of Medicine·D J Wyler
Apr 3, 2002·Seminars in Liver Disease·Laurie D DeLeveGeorge B McDonald
Apr 20, 2002·Current Opinion in Infectious Diseases·M HeydtmannD Adams
Sep 27, 2002·The New England Journal of Medicine·Michael W FriedJian Yu
Oct 24, 2002·Blood·Görgün AkpekGeorgia B Vogelsang
Feb 5, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Carmen Martinez-SierraJosé A Girón-González
Sep 2, 2003·Transplantation Proceedings·A M MainaM R Brunetto
Oct 25, 2003·Blood·Régis Peffault de LatourGérard Socié
Jan 8, 2004·AIDS Research and Human Retroviruses·Mayte Pérez-OlmedaUNKNOWN HCV/HIV Spanish Study Group
Apr 20, 2004·Bone Marrow Transplantation·C A P IvantesR Pasquini

❮ Previous
Next ❯

Citations

Jan 25, 2012·Nature Reviews. Clinical Oncology·Harrys A Torres, Marta Davila
Nov 16, 2012·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Tarik Asselah
Feb 3, 2009·Haematologica·Gérard SociéGeorge B McDonald
Oct 16, 2014·Transplantation Reviews·J P Norvell
Oct 21, 2015·Transplant Infectious Disease : an Official Journal of the Transplantation Society·J L PiñanaC Solano
Dec 30, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Andreas KyvernitakisHarrys A Torres
Jun 5, 2012·Journal of Hepatology·Emilie EstrabaudTarik Asselah
Jun 25, 2016·Annals of Hematology·Andrew J UllmannUNKNOWN Infectious Diseases Working Party of the German Society for Hematology and Medical Oncology (AGIHO/DGHO) and the DAG-KBT (Ge
Nov 2, 2016·Journal of Medical Virology·Ji-Wei LinChau-Ting Yeh
May 14, 2010·European Journal of Gastroenterology & Hepatology·Stefan ZschiedrichMatthias Breidert
Dec 18, 2014·The American Journal of Surgical Pathology·Ashley T EvansGeorge B McDonald
Feb 9, 2018·Expert Review of Anti-infective Therapy·Laura Ambra NicoliniMalgorzata Mikulska
Nov 16, 2016·ESMO Open·Matthias PinterWolfgang Sieghart

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.